Skip to main content

Fennec Pharmaceuticals Inc(FRX-T)
TSX

Today's Change
Real-Time Last Update

Fennec Pharmaceuticals Inc

68 TW Alexander Drive
PO Box 13628
Research Triangle Park NC 27709 USA
P: 919-636-4530
https://www.fennecpharma.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

    Key Executives

    NameTitle
    Robert AndradeCFO/Chief Accounting Officer
    Rostislav RaykovCEO/Director
    Adrian J. HaighCOO

    More from The Globe